Background: Decreased lung function is common in preterm-born survivors. Increased
especially in those with eosinophilic lung disease. FeNO is not only widely used as a diagnostic tool, but serial measurements have also been shown to be useful for monitoring treatment responses to inhaled corticosteroids. 10 Several studies have shown evidence of persistent abnormal lung function in later childhood for infants diagnosed with CLD. In previous systematic reviews, we have reported that preterm-born subjects have deficits in FEV 1 , increased rates of bronchial hyper-responsiveness, and single doses of bronchodilators appeared to improve FEV 1 .
11 -13 It has been reported that preterm-born subjects have higher rates of wheezing and are often diagnosed with asthma. The systematic review by Been et al. reported increased rates of wheezing in preterm-born subjects. 14 In addition, we have reported increased rates of wheezing in preterm-born children which was independent of a family history of atopy. 15 We would question the diagnostic labelling of preterm-born subjects with the label asthma, especially as the mechanisms underlying the deficits in lung function and increased rates of bronchial hyper-responsiveness remain uncertain. We believe that the mechanisms are likely to differ to asthma thus sought if FeNO was a useful diagnostic test for preterm-born children as it is for asthma.
Thus, we conducted a systematic review and meta-analysis to identify:
a) if FeNO level is increased after preterm birth when compared to term-born controls, and b) if FeNO level is increased in preterm-born subjects who had CLD compared to term-born subject.
| METHODS
We ran search strategies which included keywords relating to FeNO, preterm-birth and study design in eight databases; and additionally we searched references in the included articles to identify additional papers reporting FeNO levels in preterm-born subjects compared to term-born subjects (see Supplementary Protocol for protocol, search strategy, and data collection 
| Eligibility criteria
Studies on FeNO levels in preterm-born children and adults subjects over 2 years of age, with or without CLD compared to term-born subjects were included. Preterm-born was defined as birth at <37
weeks' gestation and term-born as birth at ≥37 weeks' gestation. We accepted the authors' definitions of CLD. All methods of assessing FeNO levels were accepted. However, only studies which reported the concentration of FeNO in the preterm-born and a comparator termborn groups were included. Studies in all languages from all countries were considered. 
| Study selection

| Data collection process
SJK data extracted data from included articles into the data tables, which were independently verified by CC. If data was not in a format which enabled the data to be included in the systematic review, the authors were contacted for further information wherever possible.
Where multiple manuscripts from the same cohort were identified, they were reviewed by SJK and SK and a decision made about which article should be included, based on the largest, most complete cohort.
| Outcome measures
FeNO level in the preterm-born subjects and in the preterm-born subjects with CLD compared with a term control group.
| Analysis of results
A formal meta-analysis was conducted for the studies which reported the mean and standard deviation, (or where they could be easily obtained) of FeNO (a) in the preterm (with and without CLD) and control groups, and (b) in the preterm with CLD group and term control group. The results of all the studies are also presented descriptively.
| Statistical analysis
Statistical analyses were performed using Review Manager (RevMan) Version 5.3. 16 After initial exploration of the data, we used random effects meta-analyses to allow for heterogeneity. Medians were converted to means using the method of Wan et al. where enough information was present to allow this to be calculated. 17 A calculator was used to convert 95% confidence intervals to standard deviation. 18 In addition, a sensitivity analysis was conducted: studies where the means and standards deviations were calculated from medians, and the single study where standard deviations were calculated from 95% confidence intervals were removed from the meta-analysis.
3 | RESULTS
| Studies selected and their characteristics
A total of 6042 article titles were identified of which 183 full articles were screened for inclusion. Nineteen met the inclusion criteria ( Figure 1 ). [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] For the three studies that overlapped data were kindly supplied by the authors. [32] [33] [34] In addition, a further author kindly supplied their data so the study could be included. 35 From the 17 studies identified, 11 (preterm n = 640 and term n = 4005)
were included in a meta-analysis and 6 are described in detail below.
The results of the meta-analysis are shown in Figure 2 . The mean difference for FeNO level between the preterm-born and term-born group was −0.74 (95% CI −1.88 to 0.41) ppb. The studies are described in detail in Supplementary Table S1 .
| FeNO in preterm group who had CLD in infancy compared to term control group
From the 17 studies identified, 6 (preterm n = 204 and term n = 211)
were included in a meta-analysis as shown in Figure 3 . The mean Table S1 .
| Sensitivity analysis
Removing the four studies where the means and/or standard deviations were calculated from the meta-analysis reporting the 
| Description of studies not included in the meta-analyses
Six studies were not included in a meta-analysis. They are described in detail in Supplementary Table S1 and briefly summarised below with data for FeNO given in ppb. In general, the preterm-born subjects with and without CLD compared to the term-born group had statistically similar or lower levels of FeNO compared to control groups. Most were excluded as they either reported data as geometric means or as medians. 6. Malmberg et al. 37 studied very low birthweight children, children with a history of wheeze and term-born children at 8-10 years of age. The FeNO levels were not significantly different between the groups once height was adjusted for (geometric mean FeNO terms 9.9, and VLBW 10.7).
| DISCUSSION
To our knowledge, this is the first systematic review and meta-analysis examining FeNO levels in preterm infants, with and without CLD, compared to infants born at term. FeNO level is generally higher in subjects with asthma, but especially in those who have eosinophilic airway inflammation. FeNO has been established as a reliable, noninvasive test for aiding the diagnosis of eosinophilic asthma, with reasonable sensitivity and good specificity. 9 A recent review studying exhaled biomarkers summarized the evidence to date with the statement that "FeNO is consequently considered a marker of a common asthma endotype characterized by Th2-mediated airway inflammation, eosinophilia, and responsiveness to inhaled steroids". 8 The results of our systematic review and meta-analyses suggest that subjects born preterm have no statistically significant difference in FeNO levels when compared to term-born subjects. Preterm-born subjects with CLD also had similar results to term-born subjects. The latter results should be treated with caution as the number of studies and total number of subjects was smaller; and the mean difference was altered by the removal of the studies where the means and/or standard deviations were calculated from medians or 95% CIs. frequently use inhaled bronchodilator treatments, are more likely to be admitted to hospital for management of wheeze or dyspnoea, and are more than twice as likely to be labelled with a diagnosis of asthma. 38 This increased respiratory morbidity appears to extend beyond childhood into adulthood. 39 However, the reasons for continuing respiratory illness in childhood and beyond remains unclear.
Our results suggest that preterm-born subjects are unlikely to have eosinophilic airway inflammation underlying their respiratory symptoms and may not have the same airway mechanics as those children with a diagnosis of asthma. The data suggest that there may be alternative underlying mechanisms to explain their episodic or chronic wheezing and symptoms of airway obstruction. Whether that is structural or functional remains to be confirmed; our recent systematic review reported increased bronchial hyper-responsiveness in pretermborn subjects compared to term-born subjects by both direct and indirect methods of measuring bronchial hyper-responsiveness. When only subjects who were preterm-born and had CLD in infancy were studied, the differences were greater, suggesting greater pathology of their airways. 13 We have also reported increased exercise-induced bronchial hyper-responsiveness in school-age children with a background of CLD which is responsive to bronchodilator therapy. 40 With increasing number of children surviving preterm-birth, it is important to understand the impact of preterm birth at a critical stage of lung development. Currently, the mechanisms underlying the increased respiratory symptoms, deficits in lung function, increased bronchial hyper-responsiveness, responses to single doses of a bronchodilator are not fully understood. Our data adds that airway eosinophilic inflammation is unlikely since FeNO level was not increased in the preterm groups including in those with CLD when compared to their term counter-parts. However, FeNO may be affected by abnormal lung development in patients with CLD, so it will be difficult to exclude completely eosinophilic airway inflammation.
We have recently shown that preterm-born subjects may have specific wheezing phenotypes. 41 It may be that specific phenotypes are associated with increased FeNO. There are suggestions that neutrophilic or oxidant injury may be continuing but these small studies need to be replicated including to identify the reasons why such injury is continuing especially given that the initial injuries most likely occurred perinatally. 
